Posts by Sandra Ansanay-Alex
Biped wins the Prix de la canne blanche
The Swiss Central Union for the Blind (UCBA) awards projects for blind, partially sighted and deaf-blind people. Twenty-one projects were submitted for the ninth edition of the competition, and the Vaud based Biped.ai won the contest. Biped – an intelligent co-pilot for blind people (picture) Biped is a co-pilot for blind people, worn like…
Read MoreThe Swiss Health Valley Region on One TV
Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch the video from 18’00. ▶️ Video link
Read Moreten23 health announces expansion with the launch of quality control services
ten23 health® announces the launch of “quality control” service offerings in Switzerland for release and stability testing of clinical and commercial sterile drug products according to international cGMP standards. The new quality control division will be set up in Basel and Visp. In Basel ten23 health® will offer physico-chemical testing, including content, purity, identity…
Read MoreComphya SA launches clinical study for erectile dysfunction in Brazil
After raising CHF 850 000 in January, and starting a clinical trial in Australia, the Swiss Medtech startup launches a clinical trial in Brazil for its neuromodulator to treat erectile dysfunction in spinal cord injured patients. Comphya SA is a pioneering medical technology company, based in canton of Vaud, Switzerland. The clinical study was…
Read MoreInnovation at Hôpital de la Tour
On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a BioAlps 4à6 event. The 70 participants discovered the “Value Based Health Care” strategy implemented by the hospital and the ambitious project of health campus. They also had the opportunity to visit the radio-oncology and the…
Read MoreLe Temps – Medtechs still trapped in European reform on medical devices
Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came into force. These changes are costly and time-consuming. ⚠️ This article was written by Etienne Meyer-Vacherand and was originally published in French in Le Temps. Two years on, the chaos caused by the…
Read MoreOncolifestyle, Debiopharm’s website to empower people living with cancer
The Swiss-based biopharmaceutical company launches a new online portal to support people with cancer, with an initial focus on prostate cancer. JULY 6, 2023 As recent studies show the importance of lifestyle habits in the management of cancer, this website has been designed to share relevant recommendations for patients, with a first focus…
Read MoreProf. Antoine Geissbuhler appointed Dean of UNIGE Faculty of Medicine
BioAlps President, Prof. Antoine Geissbuhler, takes a new position. He is now at the helm of UNIGE Faculty of Medicine. Antoine Geissbuhler is a doctor specializing in medical informatics. A full professor since 2006, he is also director of the HUG Innovation Center and head physician of the eHealth and Telemedicine Service, recognized as…
Read MoreCHUV launches a new cellular immunotherapy to treat acute myeloid leukemia
This subtype of cancer, which is particularly aggressive in children and frequent in adults, responds poorly to current standard treatments. Thanks to a private donation of CHF 2.8 million coordinated by the ISREC Foundation, the CHUV will pursue promising research, with the aim of launching a clinical trial at the end of 2024. The…
Read MoreGender medicine: Switzerland invests CHF11 million
The Swiss government is investing CHF47 million in four national research programmes: gender medicine, biodiversity, new construction techniques and crop cultivation. Some CHF11 million will be spent on enhancing knowledge of gender aspects in medical research and healthcare. The results will be translated into guidelines for doctors, nursing staff and the pharmaceutical industry.…
Read More